Brief: Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
11/09/2026 21:21
BRIEF-Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing Sept 11 (Reuters) - Nautilus Biotechnology, Inc. NAUT.O:
NAUTILUS BIOTECHNOLOGY - MAY OFFER UP TO $300 MILLION OF SECURITIES - SEC FILING
NAUTILUS BIOTECHNOLOGY - MAY OFFER UP TO $125 MILLION COMMON STOCK UNDER SALES AGREEMENT WITH TD SECURITIES - SEC FILING
Source text: [ID:n0001808805-26-000040]
Further company coverage: NAUT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nautilus Biotechnology
See all newsNautilus Biotechnology, Inc. expected to post a loss of 14 cents a share - Earnings Preview
Brief: Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
Brief: Nautilus Biotechnology Q2 EPS USD -0.11